FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

733487000: Dupilumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3499542013 Dupilumab en Synonym Active Entire term case insensitive SNOMED CT core module
3499543015 Dupilumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dupilumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Dupilumab Is a Substance with interleukin-4 receptor alpha antagonist mechanism of action true Inferred relationship Existential restriction modifier
Dupilumab Has disposition Interleukin receptor antagonist false Inferred relationship Existential restriction modifier
Dupilumab Has disposition Interleukin 4 receptor alpha antagonist true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing dupilumab Has active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing dupilumab in parenteral dose form (medicinal product form) Has active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Dupilumab Has active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing only dupilumab in parenteral dose form (medicinal product form) Has active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing precisely dupilumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing precisely dupilumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Dupilumab Inferred relationship Existential restriction modifier 1
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Dupilumab Inferred relationship Existential restriction modifier 1
Dupilumab 200mg/1.14ml solution for injection pre-filled syringes Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 200mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 200mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 200mg/1.14ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled disposable devices Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 200mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled pens (Sanofi Genzyme) Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 200mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled pens (Sanofi Genzyme) 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled syringes Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled syringes (Sanofi Genzyme) Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled syringes (Sanofi Genzyme) 2 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled syringes 6 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled syringes (Sanofi Genzyme) 6 pre-filled disposable injection Has specific active ingredient True Dupilumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start